Conditional Mineralocorticoid Receptor Expression in the Heart Leads to Life-Threatening ArrhythmiasAntoine Ouvrard‐Pascaud, Frédéric Jaisser, Anne Royer et al.|Circulation|2005Cited by 264
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 studyJacob P. Laubach, Paul G. Richardson, Fredrik Schjesvold et al.|The Lancet Oncology|2020Cited by 70
A Randomized, Double-blind, Placebo-controlled Study to Assess QTc Interval Prolongation of Standard Dose Aflibercept in Cancer Patients Treated With DocetaxelPierre Maison‐Blanche, E. Magherini, Jan B. Vermorken et al.|Journal of Cardiovascular Pharmacology|2013Cited by 5